CH Term (R4)
3.0.0 - trial-use
This page is part of the CH Term (R4) (v3.0.0: STU) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Official URL: http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-recommendation-forecast-status-cs | Version: 3.0.0 | |||
Active as of 2024-05-16 | Computable Name: SwissRecommendationForecastStatusCodesystem | |||
Other Identifiers: http://fhir.ch/ig/ch-vacd/cs/entry-conflict#entry-conflict (use: official) | ||||
Copyright/Legal: CC0-1.0 |
Immunization recommendation forecast status values.
This Code system is referenced in the content logical definition of the following value sets:
This case-sensitive code system http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-recommendation-forecast-status-cs
defines the following codes:
Additional Language Displays
Code | Deutsch (Schweiz) (German (Switzerland), de) | English (United States) (English (United States), en) | French (Switzerland) (fr) | Italian (Switzerland) (it) | rm |
due | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. |
overdue | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. |
immune | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. |
consultadvise | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. |
indicated | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. |
contraindicated | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. |
complete | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. |
notrelevant | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. |